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Abstract
Purpose and Background
Heart disease is the leading cause of death in the U.S. and costs and estimated $6 to $26 billion annually
largely due to hospitalizations. Bridging the Discharge Gap Effectively (BRIDGE) is an NP-driven transitional
care program for cardiovascular patients. BRIDGE has demonstrated lower rates of readmission for patients
with acute coronary syndrome who participated but not for atrial fibrillation (Afib) patients. We sought to
assess differences between Afib patients who participated in the BRIDGE program and those who did not.
Conceptual Framework
The BRIDGE program is based on the Bumpus Integrated Client-Focused Transitional Care Model that posits
that there exists a dynamic relationship between systems and clinicians that simultaneously influences
individual behaviors and health outcomes.
Methods
This was a retrospective study of all patients referred to BRIDGE with a primary discharge diagnosis of Afib.
Equal numbers of BRIDGE attendees were randomly matched to non-attendees. Uni-variate techniques were
used to compare groups.
Results and interpretation of results
Of 148 Afib patients referred to BRIDGE, 84 (56.8%) attended BRIDGE, 36 (24.3%) saw cardiologists or
primary care providers and 28 (18.9%) saw other providers or were unknown. There was no significant
difference in median time to follow up. In total 17 (11.5%) patients were readmitted within 30 days. Non-
attendees were more likely (71.4%) to be readmitted with afib/related diagnoses whereas attendees were less
likely (40%). There was no significant differences in incidence of comorbid CAD, HTN, CHF or vascular
disease between groups. However, of patients readmitted there was a trend toward BRIDGE attendees having
more comorbidities.
Conclusion
This study helps us to better understand readmission patterns of Afib patients. While there was no difference
in readmission rates between groups, patients who were readmitted from BRIDGE had more comorbid
conditions and were often readmitted for non-Afib conditions while those readmitted by cardiologists had
fewer comobidities but were more often readmitted with Afib/related issues. A larger sample is needed to
better understand this dichotomy and to determine what measures can be taken to enhance the BRIDGE
program for Afib patients.
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Abstract 
Purpose and Background 
Heart disease is the leading cause of death in the U.S and cosls an estimated $6 to $26 
billion annually; largely due to hospitalizations. Bridging the Discharge Gap Effectively 
(BRJDGR) is an NP-driven transitional care program for cardiovascular patients. BRIDGE has 
demonstrated lower rates of readmission for patients with acute coronary syndrome who 
participated but not for atrial fibrillation (Afib) patients. We sought to assess di11ercnces between 
Afib patients who participated in the BRIDGE program and those who did not. 
Conceptuall~'ramcwork 
The BRIDGE program is based on the Bumpus integrated Client-..Focused Transitional 
Care Model that posits that there exists a dynamic relationship between systems and clinicians that 
simultaneously influences individual behaviors and health outcomes. 
Methods 
This was a retrospective study of all patients referred to BRIDGE with a primary discharge 
diagnosis of Allb. Equal numbers of BRIDGE attendees were randomly malched to non-attendees. 
Univariate techniques were used to compare groups. 
Results and interpretation of results 
Of 148 Aftb patients referred to BRJDGE, 84 (56.8%) attended BRIDGE, 36 (24.3%) saw 
cardiologists or prim my care providers and 28 ( 18.9%) saw other providers or were unknown. 
There was no significant difference in median time to follow up. In totall7 (11.5%) patients were 
readmitted within 30 days. Non-attendees were more likely (71.4%) to be readmitted with 
;¥ 
afib/related diagnoses whereas attendees were less likely (40%). There were no significant 
differences in incidence of comorbid CAD, HTN, CHF or vascular disease between groups. 
RR!TJGE AFin PATIENT REJ\DMISSTON RATES 
However, of patients readmitted there was a trend toward BRIDGE attendees having more 
comorbidities. 
Conclusion 
4 
This study helps u,s to better understand readmission pattems of Afib patients. While there 
was no difference in readmission rates between groups, patients who were readmitted from 
BRIDGE had more co morbid conditions and were often readmitted for non-Aftb conditions 'Nhile 
those readmitted by cardiologists had fewer comorbidities but were more often readmitted with 
Afib/related isslles. A larger sample is needed to better understand this dichotomy and to 
determine what measures can be taken to enhance the BRIDGE progmm for Afib patients. 
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Insights into Readmission Rates of Atrial Fibrillation Patients Refened to BRIDGE 
In a time of escalating health care costs and American families struggling with insurance 
premiums and access to qualityhealthcare, alternative means to improve well-being are being 
sought. Practitioners across the United States are analyzing and innovating solutions to lower 
costs and improve patient outcomes. Focus on lowering readmission rates; improving patient 
outcomes and containing controllable costs are driving attention to conditions such as Atrial 
Fibrillation (afib). Afib affects more than 2.5 million adults in the United States and is predicted 
to more than double over the next 40 years. Afib is associated with significant cardiovascular 
morbidity and mmiality, and is responsible for more than $15.7 billion annually in Medicare 
costs due to disease complications (Eisenhart, 2009). Further, Medicare has estimated that of the 
$17 billion per year spent on readmissions as much as $12 billion is avoidable (Eisenhart, 2009). 
In June 2008 the Medicare Payment Advisory Commission (MedPAC) proposed to 
Congress that hospitals must publish their risk-adjusted readmission rates and further established 
payment incentives to reduce these rates (Jencks, 2009). Additionally, complementary changes 
in payment rates were recommended such that hospitals with high risk-adjusted rates of 
readmission would receive lower average per case reimbursement. With the consistent rise of 
Afib cases and readmission rates coupled by the lack of national guidelines the University of 
Michigan Cardiovascular Center decided to address this complex concern. 
Leading health care research groups such as the Michigan Cardiovascular Outcomes 
Research and Reporting Program (MCORRP) have been designing, monitoring, reporting, and 
shaping health care outcomes for cardiovascular patients for more than a decade. One such 
progran1 is "Bridging the Discharge Gap Effectively" (BRIDGE). This is a nurse practitioner 
(NP)-led program aimed to provide prompt, post-discharge, transitional care for patients who 
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experienced a cardiovascular event. Typically, transitional care for cardiac patients, when 
available, has been the role of a primary care physician or cardiologist. Yet, in the cuJTent 
climate, timely post discharge follow-up with these providers is often not available. Advanced 
practice nurses in a designated role to provide guideline-based post-discharge follow-up care are 
ideally suited to manage the complex needs of these patients. 
Background 
Heart disease is the leading cause of death for both men and women, and each year nearly 
I out 4 deaths are due to heart disease that translates to nearly 600,000 American deaths annually 
(Kochanek, Jiaquan, Murphy, Minino & Kung, 2011). Every 34 seconds someone has a heart 
attack and each minute a cardiovascular event claims life (Kochanek eta!., 2011). While 
coronary disease (i.e. heart attacks) are the mostly well-publicized cardiac conditions, other 
conditions such as heart failure and arrhythmias also account for high proportions of comorbidity 
and mmiality commonly associated with heart disease. Atrial fibrillation ( afib) for example, 
affects roughly three million Americans and the prevalence of this is expected to double in the 
United States by 2050 (Johnson eta!., 2013). Patients with this condition increase their stroke 
risk by five-fold (American Heati Association, 2013). Fmiher, in the United States alone, annual 
afib-related healthcare costs have been estimated to range from $6 billion to $26 billion per year; 
largely due to hospitalizations (Johnson eta!., 2013). In a study conducted by Kim et al. (2001) 
12.5% of patients with chronic Afib and 10.1% of patients with newly diagnosed Afib were 
readmitted to a hospital within one year of discharge with a primmy diagnosis of Afib. 
Atrial Fibrillation (Afib) is an irregular and often rapid heati rate that commonly causes 
poor blood flow to the body. The heart's two small upper chambers known as the atria beat 
irregular in a quivering manner causing a pooling and stagnation of blood. Often patients are 
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unaware that they are in afib. But for many, they feel fatigued, shmt of breath, and palpitations. 
Though this condition can be tolerated well, afib predisposes individuals to developing blood 
clots in their atria (American Heart Association, 2013). As a result of this clotting potential afib 
patients are at a stroke five-fold increase risk for stroke. (American Heart Association, 2013). 
The increased stroke risk associated with afib is attributed to the tendency for clots break into 
pieces. If a clot is small enough, it goes unnoticed. Larger pieces of clots however, can get 
lodged in blood vessels supplying fi·esh oxygenated blood to the heart resulting in a heart attack 
or in the brain resulting in a stroke. While elderly or patients with concomitant morbidities such 
as heart failure, hypertension and diabetes are at increased risk for such complications (Eagle, 
20 II); all afib patients should be screened with a standardized risk assessment tool (i.e. 
CHADS2) (Mahmood, 2012). To reduce the threat of stroke, patients with an elevated risk 
should be initiated on anti thrombotic therapy. Adequate anticoagulation concomitant with anti-
arrhytlunic therapy should not be overlooked (Eagle, 20 II). Until recently the mainstay of 
7 
anti thrombotic therapy has been warfarin. Today a few more options are available. Traditional 
management with warfarin is fraught with risk as this medication decreases ones ability to form 
blood clots. This means that it is also more difficult for these patients to stop bleeding and 
places them at increased risk for trauma and hemorrhagic strokes. Cmrently there are no 
guidelines for post-discharge follow up of afib patients. "To ensure the best possible outcome, 
atrial fibrillation management should be individualized based on patient characteristics and 
comorbidities that could influence response to specific management approaches." (Eagle, 2011). 
Yet it is clear that timely post-discharge follow-up of afib patients is essential not only for 
assessment and management of afib or response to treatments for afib, but also for assessment 
and management of anti thrombotic therapy and complications. 
BRJDGEAFIB PATIENT READMISSION RATES 
In 2007, within the University of Michigan Cardiovascular Center the BRJDGE program 
was born. A multi-disciplinary group of cardiologist and nurse practitioners were looking to 
address the readmission concerns by focusing in on the hospital-to-home transition. The 
program's mission was to provide, prompt, seamless care utilizing cardiology nurse practitioner 
(NP) services to all patients discharged after an acute cardiac event. Bridging the time gap from 
hospital discharge to first follow up appointment with a cardiologist or NP was focused upon. 
The main goals of BRJDGE were to promote compliance with evidence-based therapies, 
improve outcomes, and decrease readmissions. 
At the University of Michigan Health System Nurse Practitioners (NP) have a proven 
track record of providing access to quality care where it is lacking, thus reducing costly 
readmissions, while improving health outcomes overall for patients with cardiovascular disease. 
In a study conducted by MCORRP, patients who were seen by BRJDGE for acute coronaty 
syndrome (ACS) had significantly lower 30-day readmission rates compared to those who were 
not seen in the BRJDGE (8.5 versus 21.2 percent). In addition, BRJDGE patients had 
significantly lower 30-day emergency department visits than those who did not attend (13. 
8 
This study sought to determine the frequency with which afib patients were readmitted 
within the first 30 clays after hospital discharge, reasons for these readmissions and differences in 
readmission patterns by provider type in an effort to characterize patterns of readmission. Tlus 
study dissects the post-discharge course of atrial fibrillation (Afib) patients referred to BRJDGE 
and compares readmissions of those who attended BRIDGE to those who did not. In attempt to 
understand and recommend effective guidelines to lower readmission rates for Afib patients 
three variables were specifically examined in relation to readmission diagnosis, time to ulitial 
follow-up and co morbid conditions. 
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Methods 
BRIDGE 
Bridging the Discharge Gap Effectively is a retrospective outcomes registry of the 
preventative cardiology program. All patients discharged after a cardiac event are referred to the 
program ifthey do not have scheduled follow-up within 14 days of discharge. The BRIDGE 
program is a collaborative effort between multiple disciplines, including: nurse and 
administrative managers, schedulers, medical leadership, hospital attending physicians, medical 
residents and fellows, nurse practitioners, medical assistants, unit-based nurses, unit clerks, 
discharge planners and medical billers. BRIDGE is as a transitional care model wherein nurse 
practitioners (NPs) act as an extension of the inpatient care team. BRIDGE's primary directive is 
to provide prompt care to all patients discharged from a cardiology service or who required 
cardiology in-patient consultation until either their primary care physician or cardiologist 
resumes their care. The goals of the program are to decrease the time to follow up, to decrease 
readmissions and ED visits post-discharge, and to decrease overall healthcare costs by promoting 
evidence-based therapies, educating patients and families, scheduling follow-up tests and 
referring patients for other services as needed. 
The BRIDGE Registty is maintained by M-CORRP, and utilizes the Drupal® web-based 
registry software. M-CORRP trained research assistants abstract data retrospectively from the 
electronic medical record and enter it into the database. The data abstraction form includes 
variables for demographics, comorbidities, admission and discharge elements, treatments, and 6-
month follow-up data (Figure 1). To assure that protected health information (Pill) remains 
confidential, patients are assigned a unique participant ID. To protect PHI electronically, 
Mcrypt_ AES _ 256 enc1yption (NSA Suite B C1yptography, 2009) is used. Further, though the 
Social Security Death index was queried for patients lost to follow-up, this was done at the time 
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of data abstraction and only the result of the query were documented. To ensure data quality the 
first ten cases for all trainees are dually abstracted and entered, a fmiher 10% of all cases are 
randomly audited. Diagnostics are run on all data to identifY duplicate cases and erroneous data 
(i.e. an appointment dates years after discharge or prior to discharge). The principal 
investigators resolved any discrepancies. 
Atrial Fibrillation Study Population 
10 
For this study, all patients referred to BRIDGE with a primary discharge diagnosis of afib 
(n=148) were evaluated for inclusion in the study (see Figure 1 for the patient flow diagram). We 
next examined the distribution of patients who did not attend BRIDGE. Our target population 
for comparison are those patients who did not attend BRIDGE and whose first post-clischarge 
visit was with a cardiologist or primary care provider. We then randomly selected the same 
number of patients from the attended BRIDGE population who participated during the same time 
period. These two groups served as the comparator groups for all analysis. 
Data Analysis 
Data were analyzed using PASW 18.0. All variables were assessed for compliance with 
statistical assmnptions. Missing data were excluded from the sample. Independent student !-tests 
(continuous variables) and Chi SquaJe (categorical variables) were used to compare groups. 
Pearson's Chi-square test for significance was reported except in cases where the expected count 
would violate an underlying assumption; in these cases, Fisher's Exact test was reported. The 
significance level was set at 0.05 for all analyses. The hospital readmission rate was calculated as 
the number of patients discharged from the hospital with a diagnosis of an afib event and 
readmitted to UMHS within 30 clays, divided by the total number of people who were discharged 
alive with the same diagnosis. In order to isolate the BRIDGE effect, patients who were 
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readmitted or died prior to their initial BRIDGE appointment date were excluded. The BRIDGE 
and non-BRIDGE specific rates of readmission were calculated as the total number of 
readmissions for the BRIDGE and non-BRIDGE groups divided by the total number of subjects 
in each group. Only the first readmission following discharge for m1 afib event was counted. The 
patient was the unit of analysis. 
Results 
Of 148 Afib patients refeued to BRIDGE, 84 (56.8%) attended their BRIDGE 
appointment and 64 (43.2%) did not attend. Mean age of attendees was (71.3) years, non-
attendees (70.5) years (p=JOC); 41.7% of non attendees were male while 66.7% (n=24) of 
attendees were male. The sample that attended was mostly Caucasian (n=34; n=l African; 
American; n=1 Asian). Similarly, of those who did not attended 34 were Caucasian and 2 were 
African American. More than half of patients who did not attend had their first follow up with a 
Cardiologist/Primary Care Provider (n=36, 56.2%), 14.1% (n=9) with other Specialist and 29.7% 
(n=19) were seen outside fue institution or unknown (see Figure 1). 
In order to asce1iain the reasons for readmissions within 30 days of hospital discharge a 
retrospective chart audit for all cases was conducted. In total 17 (11.5%) patients discharged with 
a primary diagnosis of afib were readmitted within 30 days of hospital discharge (see Figure 2). 
Of those, 10 (11.9%) had pmiicipated in the BRIDGE program and 7 (10.9%) had not. More 
patients who had not attended BRIDGE were readmitted with afib or related diagnoses such as 
elevated INR, digoxin toxicity, and cerebral vasculm incidents (71.4% versus 40%) whereas 
those attended were more likely to be readmitted for non-afib related conditions such as atypical 
chest pain (60%). 
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We also sought to measure the difference in how soon patients were seen after discharge 
(see Table I). Median length of time from discharge to follow up for the entire population was 
not significant. However looking at those readmitted in <30 we see a week difference in days 
from discharge to first follow up between those who attended BRIDGE and those who did not 
attend. Patients were excluded if they were readmitted before their initial follow up. Because, 
the samples size was small for the outcome of readmission no tests for significance were done. 
Lastly we analyzed our population comparing patient comorbidities (see Table 2). No 
significance differences. However, of patients readmitted in <30 there is consistently a higher 
rate of comorbidities such as coronary miety disease, hypetiension, congestive heat failure and 
vascular disease. Again the san1ple size is too small to detetmine association. 
Discussion 
The general medicine cardiology BRIDGE program has a proven track record for 
reducing hospital readmissions within 30 days of discharge for patients diagnosed with acute 
coronary syndrome (Bumpus, 2012). Yet, BRIDGE has not shown the same success with 
patients diagnosed with afib (Bumpus, 2012). It is unclear why this is so. Within this study we 
sought to describe and explain some of the differences between patients who participated in the 
BRIDGE program and those who had usual care follow-up with a cardiologist or primmy care 
provider within the same time frame. Specifically, we compared readmission diagnoses, time to 
follow-up and readmission and comorbidity patterns between these two groups. We found that 
BRIDGE providers had more early readmissions for conditions unrelated to afib and that 
cardiologists and primary care providers had more early readmissions for afib and afib related 
sequelae. It appears that patients who attend BRIDGE NPs are more likely to also be more 
complex and potentially sicker afib patients than those seen by a cardiologist or primary care 
12 
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practitioner initially after discharge. On the other hand, it is possible that the BRIDGE NPs are 
highly specialized cardiology expe1ts and potentially have a lower threshold for admitting 
patients with diagnose other than Afib. Where as, cardiologist and other medical practitioners are 
more experienced or comfortable managing or referring patients with other issues. It is also 
impmtant to state when the patients are seen post-discharge it may impact the types of conditions 
seen by both the NP and physician. 
In considering these two possibilities above, we must also take into consideration that on 
average, patients seen outside of BRIDGE were also seen earlier than the 14 day post-discharge 
recommendation for BRIDGE. While the sample sizes are clearly too small to establish any 
significance, non-BRIDGE-attenders were seen 3 days sooner than BRIDGE attenders. Further, 
for those patients actually readmitted, non-attenders were seen a full week before those who 
attended the BRIDGE program. Fmiher analysis is required to determine whether or not the 
patients managed by cardiologists were new to the cardiologist, or if they were established 
patients as this may also affect the provider's threshold for readmission. Ultimately, to better 
understand whether or not a relationship exists between when patients are seen and reasons for 
readmissions (i.e., afib, afib related, or unrelated) will require a larger sample. 
One possible explanation is that when seen 5-13 days post discharge that is the ideal window to 
capture patients who have reverted back into afib, reh1rned to an unsustainable heart rate, or who 
suffer from some afib-related complication. Hence, the higher percentage of afib and afib-
related readmissions by the cardiologists and primary care providers. Conversely, when patients 
are not seen in the BRIDGE clinic until 12-17 days post-discharge those with afib or afib-related 
complications return to the emergency room or are readmitted (there were no deaths in this study 
sample) before their BRIDGE appointment. Therefore, the afib patients being seen in BRIDGE 
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are more stable (from an afib standpoint) and the readmissions come from the other cardiac 
conditions. It is important to note here, that we refer to appointments with their cardiologist or 
primary care provider as usual care and this in not entirely accurate. In fact, the reason the 
BRIDGE transitional care model was developed was in fact because neither cardiologist nor 
primary care physicians were able to see their patients post-discharge in a timely manner. At the 
onset of BRIDGE, typical cardiology and PCP follow-up was 20-60 days post-discharge 
(Bumpus, eta!., 2010). So despite being referred to as usual care in tllis study, patients seen by 
their cardiologist or primary care provider in less than 14 days after discharge is in fact at 
minimum an enhanced usual care. 
Within tills study the identification of factors directly affecting outcome were uncovered. 
The possibility of vmying readmission diagnoses and the length of time to the patients' first 
follow up appointment may indicate cause. For instance, on average Afib patients were 
readmitted at approximately two weeks, and non-attendees were seen approximately one week 
earlier. Finally we those readmitted in <30 days had a consistently lligher rate of comorbidities 
such as coronary artery disease, hypertension, congestive heat failure and vascular disease wllich 
states that BRIDGE is potentially seeing more complex patients. 
Limitations 
From this study it could not be detem1ined whether there is any difference in the care or 
management of Afib from delivered in comparison of the BRIDGE or the usual care model in 
part because the sample size was too small. Fmiher, one common linlitation of outcomes 
research is that results from this sample may not be generalizable to other populations given that 
the study takes place in a large Midwest academic health center. Lastly, given the time and 
financial constraints of this study, only a small (but randomized) selection of the BRIDGE 
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pmticipants were retrospectively abstracted. If repeated, this study will have more power if there 
is a 2 or 3-to-1 matching between BRIDGE participants and usual care. 
Conclusion 
In conclusion, afib is serious cardiac health condition affecting millions of Americans 
with an increasing incidence. Afib is also a condition with a trend towards high readmissions. 
As such, it is imperative to develop a transitional care model appropriate to the needs of this 
group. Despite the BRIDGE program's success with ACS, BRIDGE has not achieved these 
same outcomes with the afib population. This study begins to shed light on some of the 
transitional care differences between the BRIDGE program and usual care as provided by 
cardiologists and primary cme physicians. More work is needed in a larger sample to more fully 
understand these differences and to implement quality improvements targeted specifically at 
their needs, such as earlier follow-up. With these changes, BRIDGE may yet be a successful and 
also cost-effective model in the future. 
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Table 1. Median Time (in days) from Discharge to Follow-up n=72 
Attend (n-36) Non-Attend p-value 
(n=36) 
Time from discharge to follow-up 12.5 9.0 0.503 
Of Patients reaclrnitted in< 30 clays (n=13) 
. 
Attend (n=9) Non-Attend (n=4) 
Time from discharge to 1st follow-up 12 5.5 
Time from discharge to reaclmission 17 13 
Number seen only after readmission I (10%) 3 (42.9%) 
Table 2. Differences in Comorbidity Patterns by BRIDGE Attendance. 
· Entire Population n=72 
Comorbiclity ~ CAD HTN CI-IF Vase 
Attend n=36 17 (47.2%) 25 (69.4%) 12 (33.3%) 9 (25.0%) 
Non-Attend n=36 16 (44.4%) 20 (55.6%) 7 (19.4%) 4 (11.1%) 
P-value 0.813 0.223 0.181 0.125 
.· 
Of Patient Population Readmitted in< 30 clays 
... · . 
Comorbidity --7 CAD HTN CHF Vase 
Attend n=36 7 (70.0%) 7 (70.0%) 6 (60.0%) 5 (50.0%) 
Non-Attencln=36 3 (42.9%) 2 (28.5%) 3 (28.5%) 1 (14.3%) 
P-value 0.262 0.091 0.483 0.129 
BRIDGE AFIB PATIENT READMISSION RATES 
References 
American Hemt Association. (n.d.). Retrieved from http://www.heatt.org/HEARTORG 
/Conditions/ Arrhythmia/ AboutArrhythmia!What-is-A trial-Fibrillation-AF ib-or-
AF_UCM_ 423748_Article.jsp. 
Bumpus, S. M. (2012). A novel approach to transitional care for acute coronary syndrome 
patients. Doctoral Dissertation, University of Michigan, Ann Arbor, MI. 
18 
Bumpus, S., Kline-Rogers, E., Kosteva, A., Smith, C., Montgomery, D., Eagle, K. A., Froehlich, 
I., Jackson, E. A., Rubenfire, M. (20 11 ). A nurse based BRIDGE Transitional Care 
Model reduces readmission and ED visits. J oumal of the American College of 
Cardiology, 57(14), E1182 
Cadet,J. (2011). AF & atrial flutter remain large cost burden in U.S. Retrieved October 30, 
2013, from http://www .cardiovascularbusiness.com/topics/electrophysiology-
arrhythmia/hrs-af-atrial-flutter-remain-large-cost-burden-us?page=0%2CO 
Eagle, K., Cannom, D., Garcia, D. (2011). Management of atrial fibrillation: translating clinical 
trial data into clinical practice. The American Jomnal of Medicine, 124(1 ), 4-14. 
Eisenhart, E. (2009). Medicm-e and atrial fibrillation I consequences in cost and care. Retrieved 
October 30,2013 from http://products.sanofi.us/resources/Medicare%20and%20AFib.pdf 
Jencks, S., Williams, M., & Coleman, E. (2009). Rehospitalizations among patients in the 
Medicare fee-for-service program. The New England Journal of Medicine, 360(14), 
1418-1428. 
Johnson, B. H., Smoyer-Tomic, K. E., Siu, K., Walker, D. R., Sander, S., Huse, D., Amin, A. 
(2013). Readmission muong hospitalized patients with nonvalvular atrial 
fibrillation. American Journal of Health-System Pharmacy, 70(5), 414+. Retrieved 
BRJDGE AFIB PATIENT READMISSION RATES 19 
from http://go.galegroup.com/ps/i.do?id=GALE% 7CA322481800&v=2.1 &u= lorn_ emich 
u&it=r&p= AONE&sw=w&asid=4be3 bfb2c0cf92411272528bb2e43 94b 
Kim MH, Johnston SS, Chu BC eta!. (2011). Estimation of total incremental health care costs in 
patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 
2011; 4:313-20. 
Kochanek, K. D., Jiaquan, X., Murphy, S. L., Minino, A.M., & Kung, H. (2011). Retrieved from 
website: http:/ /www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60 _ 03 .pdf 
Malunood, R., Bumpus, S., Smith, C. A., Krishnan, S., Norville, J., Kline-Rogers, E., Froehlich, 
J., Eagle, K. A., Rubenfire, M. (2012). Bridging the Discharge Gap Effectively 
(BRJDGE): Follow-up results on the effect of the BRJDGE clinic transitional care model 
of preventing early readmissions and ED visits-6 month outcomes. Journal of the 
American College of Cardiology, 59(13, SuppA), A451 
BRIDGE AFIB PATIENT READMISSION RATES 
Appendix A 
' ' ' 
·-- •• p ~ ' •• 
... , .... '. "' 
--- ... ' 
• ' "-h~ ' -
20 
12/3/13 
1 
BRJDGE AFIB PATIENT READMISSION RATES 21 
12/3/13 
2 
BRIDGE AFIB PATIENT READMISSION RATES 22 
12/6/13 
3 
BRJDGE AFIB PATIENT READMISSION RATES 
Length (days) from 12 
DC to first follow-up 
Length (days) from 17 13 
DC.to readmission 
1 (10"1 3 (42.9%) 
Attend 17 (47.20%) 
(n ::36) 
Non-Attend 16(44.40%) 20(55.60%) 7 (19.40%) 
(n =36) 
p-value 0.813 0.223 0.181 
' ' • I •• ~, ~' '''j' t, ' • • '• ' ,• ._ , '' ' ' < 
: .· · ..... , •. _, Palfents Reailmitted In< 30 Days 
Comorbldity CAD 
Attend (n = 10) 7 (70.00'lli) 
Non-Attend 3 (42.85%) 
(n=7l 
HTN 
7 (70.00'lli) 
2 (28.50%) 
CHF 
6 (60.00%) 
3 (28.50~) 
4(11.10%) 
0.125 
VASC 
5 (50.00%) 
1 (14.28%) 
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Comorbidity 
Attend 
(n=36) 
Non~Attend 
(n=36) 
p-value 
Comorbidity 
Attend In = 10) 
Non-Attend 
(n= 7) 
CAD 
17 (47.20%) 
16 (44.40%) 
0.813 
CAD 
7 (70.00%) 
3 (42.85%) 
HTN 
25 (69.40%) 
20 (55.60%) 
0.223 
HTN 
7 (70.00%) 
2 (28.50%) 
CHF 
12 (33.30%) 
7 (19.40%) 
0.181 
CHF 
6 (60.00%) 
3 (28.50%) 
VASC 
9 (25.00%) 
4 (11.10%) 
0.125 
VASC 
5 (50.00%) 
1 (14.28%) 
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